These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17195962)

  • 1. The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients.
    Salazar-Sánchez L; Leon MP; Cartin M; Schuster G; Wulff K; Schröder W; Jiménez-Arce G; Chacon R; Herrmann FH
    Cell Biochem Funct; 2007; 25(6):739-45. PubMed ID: 17195962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
    Attié-Castro FA; Zago MA; Lavinha J; Elion J; Rodriguez-Delfin L; Guerreiro JF; Franco RF
    Thromb Haemost; 2000 Oct; 84(4):601-3. PubMed ID: 11057857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
    Margaglione M; Bossone A; Brancaccio V; Ciampa A; Di Minno G
    Thromb Haemost; 2000 Dec; 84(6):1118-9. PubMed ID: 11154124
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.
    Corral J; González-Conejero R; Iniesta JA; Rivera J; Martínez C; Vicente V
    Haematologica; 2000 Mar; 85(3):293-7. PubMed ID: 10702819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
    Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
    Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the fibrinogen beta-chain, angiotensin-converting enzyme and plasminogen activator inhibitor-1 polymorphisms in Costa Rican young adults with thrombotic disease.
    Hidalgo A; Salazar-Sanchez L; Cartin M; Mendez M; Arauz J; Parajeles A
    Cell Biochem Funct; 2010 Jul; 28(5):367-73. PubMed ID: 20535834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
    van Minkelen R; de Visser MC; Houwing-Duistermaat JJ; Vos HL; Bertina RM; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1486-91. PubMed ID: 17413037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
    Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
    Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.